Glucagon‐like peptide 1: A potent glycogenic hormone
Authors:
- Mónica MoralesMMMónica Morales
- Felipe ClementeFCFelipe Clemente
- Maria I. López-DelgadoMLMaria I. López-Delgado
- Elena DelgadoEDElena Delgado
- Almudena PereaAPAlmudena Perea
- Maria L. Villanueva-PeñacarrilloMVMaria L. Villanueva-Peñacarrillo
- 1 August 1994
- journal article
- Published by Wiley in FEBS Letters
- Vol. 349 (2) , 313-316
Abstract
GLP‐1(7–36)amide is an insulinotropic peptide derived from the intestinal post‐translational proglucagon process, the release of which is increased mainly after a carbohydrate meal; also, its anti‐diabetogenic effect in normal and diabetic states has been reported. In this study, GLP‐1(7–36)amide stimulates the formation of glycogen from glucose in isolated rat hepatocytes, such a glycogenic effect being achieved with physiological concentrations of the peptide. The GLP‐1(7–36)amide‐induced glycogenesis is abolished by glucagon, and it is accompanied by stimulation of the glycogen synthase a activity and by a decrease in the basal and glucagon‐stimulated cyclic AMP content. These findings could explain, at least in part, the GLP‐1(7–36)amide insulin‐independent plasma glucose lowering effect.Keywords
This publication has 17 references indexed in Scilit:
- Hypersecretion of Truncated Glucagon‐like Peptide‐1 and Gastric Inhibitory Polypeptide in Obese PatientsDiabetic Medicine, 1993
- Human autoantibodies react with glutamic acid decarboxylase antigen in human and rat but not in mouse pancreatic isletsDiabetologia, 1993
- Glucagon-like peptide-I-(7–37) suppresses hyperglycemia in ratsMetabolism, 1993
- Antidiabetogenic Effect of Glucagon-like Peptide-1 (7–36)amide in Normal Subjects and Patients with Diabetes MellitusNew England Journal of Medicine, 1992
- Absence of insulinotropic glucagon‐like peptide‐I(7–37) receptors on isolated rat liver hepatocytesFEBS Letters, 1991
- Glucagon‐like peptide‐1(7–36) amide is a new incretin/enterogastrone candidateEuropean Journal of Clinical Investigation, 1991
- Proglucagon products in plasma of noninsulin-dependent diabetics and nondiabetic controls in the fasting state and after oral glucose and intravenous arginine.Journal of Clinical Investigation, 1991
- Receptors for glucagon-like peptide-1(7–36) amide on rat insulinoma-derived cellsJournal of Endocrinology, 1988
- GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MANThe Lancet, 1987
- Glucagon‐like peptides activate hepatic gluconeogenesisFEBS Letters, 1987